至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

HIV-1 Vpr counteracts HLTF-mediated restriction of HIV-1 infection in T cells.

Proc. Natl. Acad. Sci. U.S.A.. 2019; 
YanJunpeng,ShunMing-Chieh,ZhangYi,HaoCaili,SkowronskiJ
Products/Services Used Details Operation
Gene Synthesis HLTFo cDNA was obtained from GenScript Get A Quote

摘要

Lentiviruses, including HIV-1, possess the ability to enter the nucleus through nuclear pore complexes and can infect interphase cells, including those actively replicating chromosomal DNA. Viral accessory proteins hijack host cell E3 enzymes to antagonize intrinsic defenses, and thereby provide a more permissive environment for virus replication. The HIV-1 Vpr accessory protein reprograms CRL4 E3 to antagonize select postreplication DNA repair enzymes and activates the DNA damage checkpoint in the G2 cell cycle phase. However, little is known about the roles played by these Vpr targets in HIV-1 replication. Here, using a sensitive pairwise replication competition assay, we show that Vpr endows HI... More

关键词

HIV-1,HLTF,Vpr,postreplication DNA repair,restric